期刊文献+

幽门螺杆菌根除失败原因及补救策略分析 被引量:1

Analysis of Common Reasons for Unsuccessful Eradication of Helicobacter Pylori and Rescue Therapy Strategy
下载PDF
导出
摘要 幽门螺杆菌(Hp)与胃炎、消化性溃疡、胃黏膜相关淋巴组织淋巴瘤及胃癌关系密切。随着根除Hp治疗在临床的普遍开展,Hp根除率逐渐下降,其主要原因是日益突出的抗生素耐药及患者对药物依从性差。对根除治疗失败者进行补救治疗已成为Hp治疗研究领域的新热点。由于各地的Hp耐药率及感染者个体情况存在很大差异,目前尚未形成统一规范的补救策略,遵循个体化的补救策略已逐渐被大家所接受。 Helicobacter pylori has closely related with chronic gastritis, peptic ulcer disease, MALT and gastric cancer. With the widespread development of Hp eradication therapy, the eradicating rate of Hp become lower and lower gradually. The main reason is increasing antibiotic resistance and the poor drug compliances of the patients. Rescue therapy for therapy failure has become a new hot spot in Helicobacter pylori research area. Due to the different antibiotic resistance rate and individual patient characteristic, there are no standard rescue schedule at present, but it has been accepted that the rescue strategy should be applied based on individuation principle.
出处 《医学与哲学(B)》 2009年第9期17-19,42,共4页 Medicine & Philosophy(B)
关键词 幽门螺杆菌 根除失败 补救治疗 Helicobacter pylori, eradication failure, rescue therapy
  • 相关文献

参考文献6

二级参考文献17

  • 1戈之铮,张德中,萧树东,陈颖,胡运彪.根除幽门螺杆菌治疗十二指肠溃疡的随机对照研究[J].胃肠病学,1999,4(4):234-236. 被引量:6
  • 2束庆文,娄诗金,刘太平,疏东升,汪全红,潘小龙,蔡善武,金小春,薛刚.奥美拉唑、左氧氟沙星、呋喃唑酮三联疗法治疗幽门螺杆菌感染[J].蚌埠医学院学报,2006,31(1):48-50. 被引量:15
  • 3Rossella Cianci,Massimo Montalto,Franco Pandolfi,Giovan Battista Gasbarrini,Giovanni Cammarota.Third-line rescue therapy for Helicobacter pylori infection[J].World Journal of Gastroenterology,2006,12(15):2313-2319. 被引量:31
  • 4Malfertheiner P, M, egraud F, O, MorainC, et al. European Helicobacter pylofi Study Group( EH. pyloriSG). Current concepts in the manangement of Helicobacter pylori infection-the Maastricht 2-2000 Consensus Report. Aliment Pharmacol Ther ,2002,16 : 167-180.
  • 5Heep M,Kist M,strobel S,et al. Secondary resistance among 554 isolates of Helicobacter pylori after failure of therapy. Eur J Clin Micrbiol Infect Dis. 2000,19,538-541.
  • 6Perri F,Festa V,Meria A,et al. Randomized study of different second-line therapiesfor Helicobacter pylori infection after failure of the standard Maastricht triple therapy. Aliment Pharmacol Ther,2003,18:815-820.
  • 7Naohito Shirai,Mitsushige Sugimoto,Chise Kodaira,Masafumi Nishino,Mutsuhiro Ikuma,Masayoshi Kajimura,Kyoichi Ohashi,Takashi Ishizaki,Akira Hishida,Takahisa Furuta. Dual therapy with high doses of rabeprazole and amoxicillin versus triple therapy with rabeprazole, amoxicillin, and metronidazole as a rescue regimen for Helicobacter pylori infection after the standard triple therapy[J] 2007,European Journal of Clinical Pharmacology(8):743~749
  • 8Jacob Yahav,Zmira Samra,Yaron Niv,Charlesnika T. Evans,Douglas J. Passaro,Gabriel Dinari,Haim Shmuely. Susceptibility-Guided vs. Empiric Retreatment of Helicobacter pylori Infection After Treatment Failure[J] 2006,Digestive Diseases and Sciences(12):2316~2321
  • 9Akihito Nagahara,Hiroto Miwa,Masato Kawabe,Akihiko Kurosawa,Daisuke Asaoka,Mariko Hojo,Katsuyori Iijima,Takeshi Terai,Toshifumi Ohkusa,Akihisa Miyazaki,Nobuhiro Sato. Second-line treatment for Helicobacter pylori infection in Japan: proton pump inhibitor-based amoxicillin and metronidazole regimen[J] 2004,Journal of Gastroenterology(11):1051~1055
  • 10Tadashi Shimoyama,Shinsaku Fukuda,Tatsuya Mikami,Michio Fukushi,Akihiro Munakata. Efficacy of metronidazole for the treatment of clarithromycin-resistant Helicobacter pylori infection in a Japanese population[J] 2004,Journal of Gastroenterology(10):927~930

共引文献167

同被引文献17

  • 1胡伏莲.《幽门螺杆菌感染若干问题共识意见》解读[J].中国医刊,2007,42(1):4-6. 被引量:51
  • 2成虹,胡伏莲,谢勇,胡品津,王吉耀,吕农华,张建中,张桂英,周曾芬,吴克利,张玲霞,彭孝伟,戴宁,唐国都,姜葵,李岩,侯晓华,白文元,王明春,叶红军,刘玉兰,许乐.中国幽门螺杆菌耐药状况以及耐药对治疗的影响—全国多中心临床研究[J].胃肠病学,2007,12(9):525-530. 被引量:518
  • 3Cover TL, Blaser MJ. Helieobacter pylori in health and disease [ J ] Gastroenterology, 2009, 136(6): 1863-1873.
  • 4Alazmi WM, Siddiqne I, Alateeqi N, et al. Prevalence of Helicobacter pylori infection among new outpatients with dyspepsia in Kuwait [ J ].BMC Gastroenterol, 2010, 10: 14.
  • 5Malfertheiner P, Megraud F, OMorain CA, et al. Management of Helico- bacter pylori infection-the Maastricht N/Florence Consensus Report [J]. Gut, 2012, 61(5) : 646-664.
  • 6Vaira D, Zullo A, Vakil N, et al. Sequential therapy versus standard triple- drug therapy for Helicobacter pylori eradication: a randomized trial [J]. Ann Intern Med, 2007, 146(8): 556-563.
  • 7Fuccio L, Minardi ME, Zagarl RM, et al. Meta-analysis: duration of first-line proton-pump inhibitor based triple therapy for Helicobacter pylori eradication [ J]. Ann Intern Med, 2007, 147 (8) : 553-562.
  • 8Jafri NS, Hornung CA, Howden CW. Meta-analysis: sequential ther- apy appears superior to standard therapy for I-Ielicobaeter pylori infec- tion in patients naive to treatment [ J]. Ann Intern Med, 2008, 148 (12) : 923-931.
  • 9Kadayifei A, Buyukhatipoglu H, Cemil Savas M, et al. Eradication of Helicobaeter pylori with triple therapy: an epidemiologic analysis of trends in Turkey aver 10 years [J]. Clin Ther, 2006, 28 ( 11 ) : 1960-1966.
  • 10De Francesco V, Zullo A, Margiotta M, et al. Sequential treatment for Helicobacter pylori does not share the risk factors of triple therapy failure [J]. Aliment Pharm Therap, 2004, 19(4) : 407-414.

引证文献1

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部